Drug Profile
Dendritic cell vaccine - Targepeutics
Alternative Names: GlioVaxLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Targepeutics
- Class Antineoplastics; Dendritic cell vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Brain cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Brain-cancer in USA
- 01 Sep 2005 Preclinical trials in Brain cancer in USA (unspecified route)